Selective histamine H2 receptor agonists alleviate blood-brain barrier disruption by promoting the expression of vascular protective factors following traumatic brain injury in mice
Open Access
- 19 August 2022
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 150 (3) , 135-145
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (20K16016)
This publication has 19 references indexed in Scilit:
- Histidine provides long-term neuroprotection after cerebral ischemia through promoting astrocyte migrationScientific Reports, 2015
- Progressive inflammation‐mediated neurodegeneration after traumatic brain or spinal cord injuryBritish Journal of Pharmacology, 2015
- Recombinant Human Sonic Hedgehog Protein Regulates the Expression of ZO-1 and Occludin by Activating Angiopoietin-1 in Stroke DamagePLOS ONE, 2013
- Effects of vascular endothelial growth factor in ischemic strokeJournal of Neuroscience Research, 2012
- Role of Histamine and Its Receptors in Cerebral IschemiaACS Chemical Neuroscience, 2012
- Multiphasic roles for matrix metalloproteinases after strokeCurrent Opinion in Pharmacology, 2008
- Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic InjuryThe American Journal of Pathology, 2007
- Edema and brain traumaNeuroscience, 2004
- Alleviation of ischemic neuronal damage by histamine H2 receptor stimulation in the rat striatumEuropean Journal of Pharmacology, 2003
- Treatment with ranitidine of ischemic brain edemaEuropean Journal of Pharmacology, 1994